‘As many as possible’: Berlin, three other German states make AstraZeneca vaccine available to ALL despite federal warning

In a bid to get people vaccinated faster, local authorities in four German states have lifted age restrictions for the AstraZeneca vaccine. On the federal level, it’s only being given to older people due to medical concerns. … Read More >‘As many as possible’: Berlin, three other German states make AstraZeneca vaccine available to ALL despite federal warning

With Germany low on Covid-19 jabs, local politician reveals country negotiating with Russia for 30 million Sputnik V doses

The premier of Germany’s Saxony region has revealed that the country wants to buy 30 million doses of the Russian-made Sputnik V Covid-19 vaccine, assuming that the EU’s European Medicines Agency approves the jab. … Read More >With Germany low on Covid-19 jabs, local politician reveals country negotiating with Russia for 30 million Sputnik V doses

EU confirms it won’t be ordering more AstraZeneca Covid-19 jabs as Europe mulls legal action

A spokesman for the European Commission has said that no decision has been made as to whether the body will pursue legal action against the Anglo-Swedish firm but confirmed reports it won’t purchase any more of its vaccine. … Read More >EU confirms it won’t be ordering more AstraZeneca Covid-19 jabs as Europe mulls legal action

Thailand says China’s Sinovac Covid vaccine safe to use after investigation into stroke-like symptoms reported in 6 recipients

Thailand has stood by its ongoing use of the Chinese Sinovac Biotech Covid vaccine following six recipients reporting stroke-like symptoms, after an inquiry found no connection between the jab and the illnesses. … Read More >Thailand says China’s Sinovac Covid vaccine safe to use after investigation into stroke-like symptoms reported in 6 recipients

India’s indigenously developed Covaxin jab 78% effective against Covid-19 in trials, maker Bharat Biotech says

The Covid-19 vaccine developed by Indian pharmaceutical firm Bharat Biotech has been found to be 78% effective in preventing symptoms of Covid-19 and 100% against severe disease in stage three trials, the company said. … Read More >India’s indigenously developed Covaxin jab 78% effective against Covid-19 in trials, maker Bharat Biotech says

Shipments of J&J Covid-19 vaccine to resume in Europe, company says after EU regulator finds benefits outweigh blood clot risks

Johnson & Johnson has said it will resume delivery of its Covid-19 vaccine to the EU after the bloc’s regulator, the European Medicines Agency’s (EMA), said the benefits of the jab outweigh any risks despite blood clot concerns. … Read More >Shipments of J&J Covid-19 vaccine to resume in Europe, company says after EU regulator finds benefits outweigh blood clot risks

EMA says J&J Covid-19 vaccine benefits outweigh the risks despite finding possible link to rare blood clots

The European Medicines Agency (EMA) has given its backing to the Johnson & Johnson Covid-19 vaccine, saying the overall benefit-risk remains positive, despite warning about the very rare possible side effect of blood clots. … Read More >EMA says J&J Covid-19 vaccine benefits outweigh the risks despite finding possible link to rare blood clots

‘One of the best protection rates’: Sputnik V maker reports over 97% efficacy after 3.8 million vaccinations

The Russian Covid-19 vaccine has an even higher efficacy rate than previously reported in the Lancet journal, its developer has said after crunching infection data from the domestic immunization campaign. … Read More >‘One of the best protection rates’: Sputnik V maker reports over 97% efficacy after 3.8 million vaccinations

Sweden halts J&J vaccine rollout until EU regulator reviews US reports of ‘very rare’ blood clot cases

Sweden won’t start vaccinating people with Johnson & Johnson’s Covid-19 shot until the European Medicines Agency (EMA) reviews reports of rare blood clots possibly caused by it in the US, the Swedish Health Agency said. … Read More >Sweden halts J&J vaccine rollout until EU regulator reviews US reports of ‘very rare’ blood clot cases